Podcasts about adar poonawalla

Havas Group, the world’s fifth-largest advertising network, counts India as one of its most successful markets. In this special Corner Office Conversation, Yannick Bolloré, Chairman and CEO of Havas Group, talks to Ratna Bhushan about why Indian branding and advertising is a “completely different world”. With several big accounts such as Reckitt Benckiser, HUL and Tata Steel and a headcount that has grown 10X in eight years and poised to double in the next few, Havas is betting big on India's booming middle class, digital-first consumers, and world-class talent base. Bolloré shares how India’s digitisation story where digital ad spends have overtaken traditional media offers a blueprint for the future. He also explains why Havas embraced AI early, how it’s slashing production costs while enabling hyper-personalised campaigns and why he wants every Havas employee to be AI-trained. Bolloré also discusses how geopolitical uncertainty from Trump’s tariffs to regional tensions continues to have an impact on advertising. Tune in.You can follow Ratna Bhushan on her Linkedin, Twitter profiles and read her Newspaper Articles. If you like this episode, check out more Corner Office Conversations from the podcast: Adar Poonawalla, Sandip Patel, The Mega Listing Of Vishal Retail, Corner Office Conversation with Philippe Schaillee, Global CEO, Costa Coffee, Antonoaldo Neves, Rajesh Jejurikar, Srikanth Velamakanni, and more! Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.See omnystudio.com/listener for privacy information.

From a modest Silicon Valley garage to a global creative powerhouse, Adobe's journey has been nothing short of transformative. In this episode of The Morning Brief, ET’s Surabhi Agarwal & Annapurna Roy engages with Adobe Chairman & CEO Shantanu Narayen to discuss how the company is integrating AI with design to redefine digital creativity. Narayen reflects on India's burgeoning creative economy, Adobe's four-layer AI strategy, and the company's "customer zero" approach to innovation. He also shares insights on how tools like Firefly are gaining unique traction in India and emphasizes that AI, when combined with human ingenuity, can elevate creative work rather than replace it.As AI redraws the boundaries of art and tech, the episode asks: Can India lead the next creative renaissance? And can Adobe stay ahead without losing its human touch?Tune inYou can follow Surabhi Agarwal on her Linkedin, Twitter profiles and read her Newspaper Articles. If you like this episode, check out more Corner Office Conversations from the podcast: Adar Poonawalla, Sandip Patel, The Mega Listing Of Vishal Retail, Antonoaldo Neves, Rajesh Jejurikar, Srikanth Velamakanni, and more!Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.See omnystudio.com/listener for privacy information.

From Carnegie Mellon classrooms to a global cultural phenomenon, this episode of The Morning Brief traces the journey of Luis von Ahn, math prodigy, inventor of CAPTCHA, and now the CEO and co-founder of Duolingo. Hosts Anirban Chowdhury and ET’s Deputy news editor Himani Kothari explore how Luis’s early work fighting bots evolved into a business to democratize education through gamified language learning. What began with a Spanish course and a German prototype has grown into a plus 500-million-user platform, driven by Duolingo’s bite-sized lessons, quirky owl mascot, and irreverent marketing strategy. The conversation delves into the company’s expansion into math, music and chess, its partnership with OpenAI, and the creative freedom that powers its viral success. As AI becomes central to the future of learning, Luis weighs its potential to enhance not replace human education. Can platforms like Duolingo balance fun, function, and cultural impact in a world increasingly shaped by algorithms?Tune in: You can follow Anirban Chowdhury on his Linkedin, Twitter profiles and read his Newspaper Articles. You can follow Himani Kothari on her Linkedin, Twitter profiles and read his Newspaper Articles. If you like this episode, check out more Corner Office Conversations from the podcast: Adar Poonawalla, Sandip Patel, The Mega Listing Of Vishal Retail, Antonoaldo Neves, Rajesh Jejurikar, Srikanth Velamakanni, and more!Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.See omnystudio.com/listener for privacy information.

India once seen as a tea stronghold is emerging as a dynamic market for premium coffee. One brand leveraging this pivot is Costa Coffee. The British coffee house has a strange business arrangement in India. Owned by Coke, its outlets are operated by Pepsi’s biggest Indian bottler. Nevertheless and unfazed by growing competition from premium coffee names like Blue Tokai and Tim Hortons, Costa counts India as one of its top markets and wants to expand its footprint of 200 outlets in the near future. In this episode, Philippe Schaillee, Global CEO at Costa Coffee, talks to host Ratna Bhushan about how the legacy brand is blending tradition with the agility of a startup to win over a new generation of coffee enthusiasts. From Gen Z’s growing appetite for cold brews and flavored options to navigating post-COVID inflation without compromising on quality, Philippe breaks down Costa’s business strategy for a market that is really waking up and smelling the coffee. He sheds light on the company’s city-focused growth strategy, the role of local partnerships, and what sets Costa apart in a fiercely competitive, youth-driven market. Stay tuned in as we explore What makes a coffee experience aspirational today? Can global brands win by going hyper-local? And is India the future powerhouse of the global coffee revolution?Tune in You can follow Ratna Bhushan on her Linkedin, Twitter profiles and read her Newspaper Articles. You can follow Philippe Schaillee on his Linkedin, Twitter profiles and read his Newspaper Articles. If you like this episode, check out more Corner Office Conversations from the podcast: Adar Poonawalla, Sandip Patel, The Mega Listing Of Vishal Retail, Antonoaldo Neves, Rajesh Jejurikar, Srikanth Velamakanni, and more!Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.See omnystudio.com/listener for privacy information.

Eli Lilly has launched its obesity and diabetes drug Mounjaro (Tirzepatide) in India. Weight loss drugs, a pharmaceutical segment that has taken the world by storm, has catapulted Eli Lilly to being the world’s most valuable company with a market cap of over $800 billion. In this episode, ET’s Vikas Dandekar and Teena Thacker speak with global CEO David Ricks and Winselow Tucker, President & GM India, about new breakthroughs in drug development, competition, and the role of emerging markets. They also discuss strategic partnerships, political challenges like tariffs, and Eli Lilly’s commitment to funding innovation and advancing global healthcare. Tune in.You can follow Vikas Dandekar on his Linkedin, Twitter profiles and read his Newspaper Articles. You can follow Teena Thacker on her Linkedin, Twitter profiles and read his Newspaper Articles. If you like this episode, check out more Corner Office Conversations from the podcast: Adar Poonawalla, Sandip Patel, The Mega Listing Of Vishal Retail, Antonoaldo Neves, Rajesh Jejurikar, Srikanth Velamakanni, and more!Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.See omnystudio.com/listener for privacy information.

For McDonald’s, India presents a consistent growth in contrasting the headwinds its facing globally. That story has been charted by Westlife Foodworld, McDonalds top seller in India since it opened its first local store in Vasant Vihar, New Delhi in 1996. In this episode, Host Anirban Chowdhury talks to Akshay Jatia, President and CEO of Westlife talks about how he sees the Indian QSR story evolving, the growing importance of tier II and III cities to McDonald’s growth in India, what he thinks of competition like Good Flippin Burgers, why he won’t hive off McCafe into an independent entity and much more. Tune inIf you like this episode, check out more Corner Office Conversations from the podcast: Adar Poonawalla, Sandip Patel, The Mega Listing Of Vishal Retail, Antonoaldo Neves, Rajesh Jejurikar, Srikanth Velamakanni, and more!You can follow Anirban Chowdhury on his social media: Twitter and Linkedin Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.See omnystudio.com/listener for privacy information.

The rapid development of the Covid-19 vaccine and the ramp-up of manufacturing and global distribution were unprecedented feats of medical coordination. But those on the inside say it could have gone even smoother and faster, and if we implement the lessons learned we'll be in much better shape if another pandemic hits. Unfortunately, most global leaders seem to want to just move on and prioritize other issues, according to Adar Poonawalla, the CEO of vaccine company Serum Institute of India. His firm is one of the only family-owned medical manufacturers, and they were able to scale up production dramatically to help provide the Covid vaccine to people in developing and lower-income countries at an affordable cost. He talks with author and journalist Michael Lewis at the 2024 Aspen Ideas Festival about what it was like to have such a pivotal role in a global health crisis and what it would take to keep facilities like his ready to jump into action again. aspenideas.org

Shipping giant AP Moeller Maersk just announced its biggest investment commitment to India: $5 billion. The investment will mostly be spent in trying to renew an existing port contract and bidding for a new one. But are there other projects on the anvil? What about logistics and shipbuilding? The company has been slower than its rivals to expand: globally and in India. But will a recent blockbuster profit and an overhaul of the network unleash its animal spirits? Host Anirban Chowdhury talks about it all with Keith Svendsen, Chief Executive Officer, APM Terminals and Christopher Cook, Managing Director, India, Bangladesh and Sri Lanka. If you like this episode, check out more Corner Office Conversations from the podcast: Adar Poonawalla, Sandip Patel, The Mega Listing Of Vishal Retail, Antonoaldo Neves, Rajesh Jejurikar, Srikanth Velamakanni, and more!You can follow Anirban Chowdhury on his social media: Twitter and Linkedin Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.See omnystudio.com/listener for privacy information.

India’s gaming industry is experiencing growth, driven by millions of players, a rapidly expanding esports culture, and increasing investments in game development. However, behind this success lies a complex landscape of regulatory challenges, evolving technology, and changing player preferences. In this episode, host Anirban Chowdhury sits down with Sean (Hyunil) Sohn, CEO of Krafton India, to discuss his journey, Krafton’s experience in navigating bans and regulations, and the company’s vision for the Indian gaming market. They explore how artificial intelligence is transforming game development and player experiences, Krafton’s $160 million investment in Indian startups, the rise of cloud gaming, and what the future holds for gaming in India over the next decade. If you like this episode, check out more Corner Office Conversations from the podcast: Adar Poonawalla, Sandip Patel, The Mega Listing Of Vishal Retail, Antonoaldo Neves, Rajesh Jejurikar, Srikanth Velamakanni, and more!You can follow Anirban Chowdhury on his social media: Twitter and Linkedin Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.See omnystudio.com/listener for privacy information.

Tata Consumer Products has been on a transformative journey, evolving from a tea and salt company into a diversified FMCG business. With changing consumer preferences, rising competition, and the rapid growth of digital commerce, the company is navigating a dynamic landscape while expanding its footprint across multiple categories. Host Ratna Bhushan talks to Sunil D’Souza, CEO & MD of Tata Consumer Products discussing the company’s ambitions to become an FMCG leader, earnings, urban vs. rural demand trends, the evolving premiumization landscape in India, Starbucks, acquisitions, Trump and much more.Tune in. If you like this episode, check out more Corner Office Conversations from the podcast: Adar Poonawalla, Sandip Patel, The Mega Listing Of Vishal Retail, Antonoaldo Neves, Rajesh Jejurikar, Srikanth Velamakanni, and more!You can follow Ratna Bhushan on her social media: Twitter and Linkedin. Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.See omnystudio.com/listener for privacy information.

Between finance minister Nirmala Sitharaman’s tax sops for the middle class and Donald Trump’s tariff missiles on three countries he really dislikes, it’s been a largely eventful three days. And as usual, The Morning Brief is buzzing with questions: From tax cuts and fiscal discipline to capital expenditure, is the so-called “impossible trifecta” too good to be true? Why was a tax bill introduced separately from the budget? Is the government pivoting from corporate India to the middle class? Trump’s latest executive decision can put global trade in limbo and has thrust the world into very uncertain times. What lies ahead? Host Arijit Barman talks to Swaminathan Aiyar about it all. And more…Tune inIf you like this episode, check out more Corner Office Conversations from the podcast: Adar Poonawalla, Sandip Patel, The Mega Listing Of Vishal Retail, Antonoaldo Neves, Rajesh Jejurikar, Srikanth Velamakanni, and more! You can follow our host Arijit Barman on his social media: Twitter and Linkedin Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.See omnystudio.com/listener for privacy information.

At the Davos World Economic Forum Arijit Barman had an insightful conversation with Nicolai Tangen, CEO of Norges Bank Investment Management, about managing one of the world’s largest sovereign wealth funds. From the rise of AI and Big Tech dominance to the impact of geopolitical tensions and shifting energy policies, Tangen breaks down the forces shaping global finance. He also shares insights on the role of India in the investment landscape, the risks of market concentration, and why transparency is key in managing $2 trillion. If you like this episode, check out more Corner Office Conversations from the podcast: Adar Poonawalla, Sandip Patel, The Mega Listing Of Vishal Retail, Antonoaldo Neves, Rajesh Jejurikar, Srikanth Velamakanni, and more! You can follow our host Arijit Barman on his social media: Twitter and Linkedin Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.See omnystudio.com/listener for privacy information.

Parth Jindal, Managing Director, JSW Cement and Priya Aggarwal Hebbar, Chairperson, Hindustan Zinc talk to Arijit Barman about the yeas and nays of Davos 2025, the most interesting people they met there, overdoing AI, navigating China and ESG and wokeism in the Trump era. If you like this episode, check out more Corner Office Conversations from the podcast: Adar Poonawalla, Sandip Patel, The Mega Listing Of Vishal Retail, Antonoaldo Neves, Rajesh Jejurikar, Srikanth Velamakanni, and more! You can follow our host Arijit Barman on his social media: Twitter and Linkedin Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.See omnystudio.com/listener for privacy information.

Arijit Barman is joined by Adar Poonawalla, CEO, Serum Institute of India, at the World Economic Forum 2025 where he sheds light on concerns around Trump’s pullout from the WHO, progress in achieving vaccine equity, status of key projects like the HPV vaccine to combat cervical cancer, and upcoming vaccines for malaria, dengue, and chikungunya. He also discusses the institute’s $2 billion investment in cutting-edge research and facilities, the use of AI to aid clinical trials, and the development of needle-free vaccine delivery methods. Beyond healthcare, Poonawalla highlights his strategic diversification from financial services and insurance to films and music labels. Tune in:.If you like this episode, check out more Corner Office Conversations from the podcast: S. Jaishankar, Ravi Kant Jaipuria,Arjun Nohwar, Manoj Chacko, G.V. Prasad, Dara Khosrowshahi, Henry Kravis, Campbell Wilson, Warren K. Harris,Nithin Kamath, Corner Office Conversation With Monika Shergill, VP, Content, Netflix India and more!You can follow our host Arijit Barman on his social media: Twitter and Linkedin Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts,JioSaavn, Amazon Music and Google Podcasts.See omnystudio.com/listener for privacy information.

At London Property we help you make informed decisions and make more money from your property by reducing costs & expensive mistakes. If you have a property question, we would love to hear from you email us at ask@londonproperty.co.uk or book a free 15 minute call by texting 07860 343434.https://www.londonproperty.co.uk/en/london-property-news-bulletin-19th-december-2023/Join us on a journey through the UK's evolving housing landscape in this comprehensive roundup for December 19, 2023. First, delve into the property market's seismic shift as Indian billionaire Adar Poonawalla makes headlines with the £138 million purchase of Aberconway House in Mayfair, London—the largest property acquisition of 2023. Poonawalla, known as the 'vaccine prince,' adds a historic chapter to London's real estate history.Next, witness the National Association of Property Buyers sounding the alarm on the escalating rental crisis in the UK. Jonathan Rolande, spokesperson for NAPB, outlines five controversial steps to tackle the crisis, urging immediate government intervention to address the supply shortage and ensure affordable housing for millions facing difficulties.Transitioning to financial matters, discover HMRC's response to concerns over stamp duty overpayments. Learn about potential refunds averaging £27,000, but with cautionary notes from HMRC about incorrect claims and potential consequences. The intersection of tax policies, property market dynamics, and individual financial burdens unfolds in this segment.In a landmark conclusion to the 'trial of the century,' Cardinal Angelo Becciu receives a five-and-a-half-year prison sentence for embezzlement in a case exposing financial misconduct surrounding a multi-million-pound investment in a luxury London property. Explore the implications for Vatican reform and Pope Francis's legacy in this significant development.Finally, explore the broader narrative of the UK's housing crisis, transcending financial strains to impact social aspects. From Lambeth to Barking and Dagenham, we navigate through diverging narratives within the city—school closures, workforce concerns, and a looming political reckoning. Understand the multifaceted challenges posed by rising housing prices, affordability woes, and their far-reaching effects on urban communities.Join us as we unravel the threads of these interconnected stories, highlighting economic, social, and political dimensions, emphasizing the urgent need for comprehensive solutions to secure the vitality and inclusivity of urban communities across the UK. Don't miss this insightful exploration of the forces shaping the nation's housing destiny on December 19, 2023.#HousingCrisis #PropertyMarket #UKRealEstate #VaticanVerdict #RentalCrisis #StampDuty #AffordableHousing #PopeFrancis #AdarPoonawalla #NAPB #HMRC #CardinalBecciu #LondonRealEstate #UrbanChallenges #HousingInequality #CityLiving #FinancialNews #RealEstateTrends

Yohan Tengra is an anarchist, an activist, an investigative journalist, functional medicine expert and the national steering committee member of Awaken India Movement. He is the founder of Anarchy For Freedom. In this episode, we talk about the deletion of his YouTube channel Anarchy For Freedom, allegations on Russell Brand, US presidential candidates, Citizens' Court of India, SSR's murder mystery, twitter beef with Dr. Abby Philips aka The Liver Doc, legal tussle with Adar Poonawalla, diet evangelists, Anarcho-Capitalism & his future plans. Recorded September 23, 2023 Instagram: https://www.instagram.com/thelabyrinth.podcast/ Podcaster: Pratham Padav | Twitter: @prathampadav_ | Telegram: Projectionist Guest: Yohan Tengra | Twitter: https://twitter.com/ytengra | Website: https://anarchyforfreedom.in/ 

बातम्या सविस्तर जाणून घेण्यासाठी क्लिक करा.....सकाळच्या पॉडकास्टला...1. WHO Alert : 'थोडी किंवा जास्त प्या शेवटी या आजाराचा धोका कायम' WHOचा मद्यपिंना सूचक इशारा2. Adar Poonawalla : 'जगाच्या तुलनेत भारताची स्थिती चांगली, लवकरच Covavax ला बूस्टर परवानगी मिळेल'3. OBC News : केवळ दोन महिन्यांमध्ये होईल ओबीसी जनगणना! कसं ते भूजबळांनीच सांगितलं4. पालकांना वस्तू विकण्यात मदत करणारी मुलं 'बालकामगार' होऊ शकत नाहीत - High Court5. शिवसेनेत दोन गट पाडणं, हे भाजपचंच मिशन; भाजपच्या या बड्या नेत्याची कबुली6. साऊथचा 'हा' बिग बजेट चित्रपट करणार राडा, तीन सुपरस्टार दिसणार एकत्र!7. टीम इंडियाला धक्का; Jasprit Bumrah वनडे सीरीजमधून आऊट8. चर्चेतील बातमी - एकाच महिन्याचे कपडे घेऊन गेलो होतो,पण झालं उलटचं...बिग बॉसचा विजेता अक्षयची पहिली प्रतिक्रिया

Somewhere in May last year, when the second wave of pandemic was in the full swing, India was struggling to vaccinate its people. The government and vaccine makers were trading charges while Covid-19 was taking a heavy toll on human lives. India, which was home to the world's largest producer of Covid-19 vaccine, failed to inoculate the entire population during the course of that lethal wave. But a few months on, by the month of July, India became the only country after China to administer over two billion Covid vaccination doses. The vaccination drive, on scale, was hailed as one of the best in the world. So far, over 98% of adults have received at least one dose of the Covid vaccine, while 90% have been fully vaccinated. Nearly 22.7 million doses are available with states as of October 1. And just about 15 months later -- by the end of September -- over 100 million doses of vaccines ended up being wasted as their shelf life expired. Were there no takers of these booster doses or they simply didn't reach the needy? The loss, pegged at Rs 2,250 crore, fades in front of the loss it may have cost to people's health as the world is still facing acute vaccine inequality. The shelf life of Covishield is currently nine months, while that of Covaxin is 12 months. The shelf lives of both the vaccines were extended by three months last year. Non-Covid vaccines typically have a shelf life of three years. Why were 100 million doses wasted? As the pandemic waned, people became complacent. Masks disappeared from public places and there were few takers for booster doses. Over 84% of India's population is eligible for booster dose, but only 27% of them have received the shot. The booster coverage improved, thanks to a 75-day free booster dose campaign by the Centre. In mid-July, the booster dose coverage was at a meagre 8%. Despite the gains, India still has a long way to go in improving booster coverage. Had it not been the free booster dose campaign, the wastage would have been higher. In an interaction with Business Standard earlier, Adar Poonawalla indicated that he was trying to save around 50-100 million doses of vaccines in a free booster dose drive. Some amount of vaccine wastage is inevitable with such a large vaccination drive, however, governments try to minimise the damage. For all vaccines, GAVI recommends countries to keep the maximum wastage of 25% for the first year, with gradual reduction to 15% by the third year. For Covid vaccines, GAVI assumed the wastage rate could be 10%. If we look at the global scenario, the number of Covid-19 vaccines which are likely to have been wasted since the global roll out began is estimated to be 1.1 billion as of mid-July, according to data analytics firm Airfinity. “While wastage at any level is undesirable, it is the result of unprecedented vaccine production which has saved millions of lives. If we want a fast reacting global vaccine response system, we will have to accept some level of wasted doses,” says Airfinity CEO, Rasmus Bech. The other major reason why so many doses ended up being wasted in India was because of mis-anticipation of demand. Experts say companies were unclear about the purchase orders from the Centre and ramped up capacity in a big way. Serum had accumulated 250 million doses of formulated vaccines, and another 250 million in the bulk form by December last year and stopped Covishield production. Bharat Biotech too had a stock of 50 million doses lying at its plants around April and had halted production of Covaxin. The restrictions on exports did not help either. As India grappled with a deadly second wave in April last year, the government halted vaccine exports and resumed only towards the later end of the year. The restrictions meant that vaccine makers might have missed out on some of the export orders.  Prof Y K Gupta, member of the National Expert Group on Vaccine Administration for Covid-19, tells more Prof Y K Gupta, For

Indian startups are shedding the extra flab put on during the days of easy money. Layoffs and cost restructuring are the only way out for them now. Some of India's largest start-ups are in the middle of a transition. They are shifting from growth to profitability now.  Innovation has also been the key to the success of Adar Poonawalla. He has taken Indian vaccines to the US and European markets. In an interview with Business Standard's Sohini Das, Poonawalla tells about his plans, which include mass production of malaria vaccines, nasal flu vaccine and exploring a vaccine for monkeypox too.    Adar Poonawalla had recently asked Elon Musk to invest in India if his Twitter deal doesn't go through. The SII chief promised Musk on Twitter that it would be the best investment he would ever make. Meanwhile, the Indian rupee has reversed its slide recently amid a weakening in the US dollar index, and a halt in foreign investors' selling spree. We delve into the outlook for the currency and the sectors that can benefit the most from the current trend. Just like the equities, experts advise caution in purchase of property too. But how will you know if the house you are planning to buy is free of any litigation or any other problem. An Encumbrance Certificate will help you in that. Let us know more about it in this episode of the podcast.   

Innovation has also been the key to the success of Adar Poonawala. He has taken Indian vaccines to the US and European markets. In an interview with Business Standard's Sohini Das, Poonawalla tells about his plans, which include mass production of malaria vaccines, nasal flu vaccine and exploring a vaccine for monkeypox too. Let us listen in to the interview in this podcast. 

CWC to meet today to review panels' plans on key issues, Probe ordered in case of Khalistan flags hung at entrance of Himachal assembly, Adar Poonawalla has reached out to Elon Musk to invest in India and other top news in this bulletin.

On the last day of 2021, we take a brief summary of three personalities and a company which stood apart from the rest. They were the torchbearers of hope in an otherwise grim year. We start with Phalguni Nayar, a former investment banker who took an entrepreneurial plunge at the age of 50 with her beauty start-up Nykaa. This year, she became India's wealthiest self-made woman after her blockbuster IPO debut. Then, of course, “prince of vaccine” Adar Poonawalla. The owner of the world's largest vaccine making company Serum Institute of India (SII), who helped us fight Covid-19. He is followed by ace investor Rakesh Jhunjhunwala. And the company of the year is Tata group, whose bold move to acquire ailing Air India revealed its sound financial health.  From the newsmakers who defied pandemic, let us see how this year was for the markets. It has been a rollercoaster ride for the Indian equity markets that navigated multiple headwinds and yet notched up smart gains in calendar year 2021. As we draw curtains to the year, the big question on investors' minds is whether the bull-run will continue in 2022. Here is a quick check on how the indices performed in 2021 and which stocks made you money in the year gone by.  Investors are hopefull that the stocks will continue their upward momentum in the next year too. 2022 may well hold answers to many of our curious questions too, which popped up this year. Will Metaverse, Web 3.0, Blockchain and NFT change everything as promised by expanding our virtual universe? Or they are just hype. Let us find out more about these terms which became tech buzzwords of 2021 and more in this episode of the podcast. Watch video

Falguni Nayar In the male-dominated clique that is India Inc, few women have gained entry. India's women labour participation rate is just 21%, and one would be surprised that even in the upper echelons of the Indian business world, with all their talk of gender inclusion, female representation is dismal. In 2019, out of 1,814 chief executives and MDs of NSE-listed companies, only 67, or 3.69% were women. And last year, India had just one woman chief executive among Nifty50 companies, just as in 2019. Given this state of affairs, Nykaa CEO Falguni Nayar, much like her startup, is a unicorn. The entrepreneurial bug bit her when she was 50. And the online internet beauty business was a complete break for Nayar, who came with 18 years of experience as an investment banker with Kotak Mahindra.  In November this year, nine years after being founded in 2012, Nykaa's parent company FSN Ecommerce Ventures listed on Indian bourses. While 2021 saw several startups going for IPOs, Nykaa was one of the rare ones that was profitable.    As Nykaa's valuation crossed the Rs 1 lakh crore mark after its public listing, the net worth of Nayar, who owns around 52.56% stake in the company, surged to $7.90 bn. In the process, Nayar, an alumnus of IIM Ahmedabad, has become the wealthiest self-made woman in India and is among the country's 20 richest people, the only woman in this all-boys club, or as various publications have called it: the Nykaa among Nayaks. Adar Poonawalla Someone who is on the Time Magazine's “100 Most Influential People Of 2021” list, is an obvious choice for this wrap. The only son of Cyrus Poonawalla -- who established the Serum Institute of India (SII) in 1966-- Adar Poonawalla was sent to boarding school in London when he was nine years old. Adar returned over a decade later with a degree in business management from University of Westminster and joined the family business in 2001, without even an official designation. The next decade was spent under the shadow of his father, before Poonawalla became CEO of the company in 2011. And his moment of reckoning took almost another decade to arrive, when the world was under the grip of pandemic. Rising to the occasion, Poonawalla took a “calculated risk” and ramped up vaccine production, without waiting for government sanctions. The 40-year-old pumped in around $800 Mn into his company's Pune facility to manufacture millions of doses of the then unproven AstraZeneca vaccine against Covid-19. At the beginning of this year, SII delivered its first batch of AstraZeneca/Covishield vaccines for the Indian population. As of now, over 80% of the Indian population has received at least one shot. And over 90% of them had rolled up their sleeves for Covishield.   But Poonawalla had his share of controversies. His plan of exporting a large chunk of its Covishield output hit a roadblock when the deadly second wave of Covid-19 hit India in April. By that time, just about 2% of India's population was fully vaccinated. India banned the export of vaccines, hitting the supply of Covishield to poorer countries. While many hailed Poonawalla for SII's role in India's vaccination drive, global commentators flagged what they called lack of transparency in his statements. In June 2020, Poonawalla had said that his company would manufacture one billion doses of Covishield for low and middle income countries, of which, 400 million would be ready by the end of 2020. But, in January 2021, SII had a stockpile of just 70 million doses. Poonawalla also faced criticism for offering the vaccine at different rates to the Centre and the state governments. Nevertheless, as the year draws to a close, Poonawalla's, and consequently, India's worries, seem to have eased somewhat. The company recently announced that it will reduce Covishield production by half as it has fulfilled its orders to the Indian government and has a stockpile of 500 million do

Dipali Ojha is an advocate from the Indian Bar Association. She has been fighting tirelessly against vaccine mandates, lockdowns and the pharma mafia. She and her husband Adv. Nilesh Ojha have previously sued the WHO and have recently filed a murder case against Bill Gates and Adar Poonawalla. In this episode, we talk about the pandemic hysteria, vaccine mandates, lockdowns, the awakening of Indian people, discrimination and inhumane treatment of the unvaccinated, vaccine deaths, lockdown compensation and more. Recorded December 3rd, 2021 Instagram: https://www.instagram.com/thelabyrinth.podcast/ Podcaster: Pratham Padav | Instagram: @prathampadav | Twitter: @whoispadav Guest: Dipali Ojha | Twitter: https://twitter.com/dipali_adv | Indian Bar Association Website: https://indianbarassociation.in/ Notes: Application for compensation due to lockdown by Awaken India Movement: https://awakenindiamovement.com/application-for-compensation-due-to-lockdown/ World's first vaccine murder case against Bill Gates, Adar Poonawalla filed in India's High Court: https://indianbarassociation.in/worlds-first-vaccine-murder-case-against-bill-gates-adar-poonawalla-filed-in-indias-high-court/

(UPDATE : SII HAS NOW APPLIED FOR VACCINE APPROVAL BY EUROPEAN MEDICINES AGENCY)        

The 50-pack Nifty could make a dash for another record high in today's trade, boosted by a better than expected GDP print, firm global cues and easing coronavirus cases. At 7.40 am, SGX Nifty was ruling 65 points higher at 15,645. Amid the coronavirus pandemic, India's GDP grew at 1.6 per cent in the January-March quarter of the fiscal year 2020-21, higher than the market forecast of 1 per cent, but witnessed a contraction of 7.3 per cent for the entire fiscal year. Even then, the figure beat the CSO's estimate of 8 per cent contraction. Analysts believe the better than expected data will provide relief to the central bank as it announces its credit policy later this week. Meanwhile, on the global market front, most Asian stocks were steady as traders await a host of manufacturing activity and key American jobs data later in the week to help assess the economic outlook. While Japan's Nikkie 225 declined 0.34 per cent, South Korea's Kospi added 0.82 per cent and Hong Kong Hang Seng rose 0.24 per cent. US markets were shut on Monday for a holiday. In other news, the 75 per cent margin norms will come into effect from today onwards. Market players fear this move will further dent volumes, particularly in the intraday cash and future segments. Now, a look at the stock-specific triggers that are likely to guide the market today A total of 17 companies are slated to post their March quarter numbers today, including ITC, Balrampur Chini Mills, Gujarat Gas and Radico Khaitan. Analysts expect ITC to post high single-digit revenue growth on a yearly basis during the quarter under review, although the profit after tax (PAT) is expected to fall. Shares of auto companies will be in focus as automakers will report May sales figures between June 1-2. Experts eye a double-digit decline across segments, especially in the two-wheeler and commercial vehicles space, while the impact on tractors and the passenger vehicle segments could be lesser. Defence stocks will be on investor radar today after the Defence Ministry on Monday notified the second negative import list of 108 items that can now be only purchased from indigenous sources. Jammu & Kashmir Bank will consider the proposal of capital infusion in the bank by the state government as its promoter shareholder to the extent of Rs 500 crore on June 4. The Board of Magma Fincorp on Monday appointed Adar Poonawalla as the Chairman and Abhay Bhutada as the Managing Director. Vijay Deshwal, a seasoned banker currently with ICICI Bank, will take charge as CEO of Magma Fincorp from July. He will also be the Group CEO.

The Serum Institute of India has been at the center of vaccine production for COVID-19. But as the second wave crashes down on the country, an export ban via the Indian central government has put the company in a tough spot, with CEO Adar Poonawalla even fleeing to London. SII is at a point where it no longer holds the promise of production monopoly, and must expand to newer geographies and technology to strengthen its position as a global biotech company.   Story originally reported by Seema Singh https://the-ken.com/story/adar-poonawallas-bid-to-vaccinate-serum-institute-against-all-threats/    News clips sourced from NDTV.   Hosts Anushka Chhikara Olina Banerji   Music and editing by Sameer Rahat from Baqsa Studios. Special offer for our podcast listeners: https://the-ken.com/podcastoffer/ Follow us on twitter: https://twitter.com/TheKenWeb Psst share your feedback with us on podcast@the-ken.com

This week, we discuss our instinct to flee during a crisis, and whether there can be a responsible way to check out.

C-17 Globemaster III fleet is now at the centre of IAF's efforts for Covid-19 relief, Biden wants 70% of American adults to have received at least one shot of the vaccine, Adar Poonawalla turned down $1 billion offer & other top news in this bulletin.

As BJP loses the West Bengal assembly election, Shekhar Gupta takes stock of the implications it has on the national politics and what possibilities does it open up for the Congress. Also, a look at Adar Poonawalla's remarks on severe vaccine shortage in India in coming months, in episode 738 of #CutTheClutter,

Sacré meilleur entrepreneur de l’année en Inde, Adar Poonawalla dirige depuis 2011 le Serum Institut of India. La pandémie de Covid-19 a mis sur le devant de la scène ce patron au physique de jeune premier que le magazine Forbes a classé parmi les 40 personnalités de moins de 40 ans les plus influentes de la planète.

Adar Poonawalla said his company hopes to launch the second vaccine against Covid-19 by September, Sachin Tendulkar tests positive for Covid-19, Delhi's Satyendar Jain ruled out the possibility of a lockdown & other top news in this bulletin.

Today on The Leaders' Brief - In a much needed positive development for the US economy, nonfarm payrolls surged by 379,000 jobs in February after rising 166,000 in January. However, it will be a while before the USA can make a full recovery of its job sectors after the COVID-induced devastation. According to the US Labor Department at least 4.1 million Americans have been out of work for more than six months, accounting for 41.5% of the unemployed population in February.  In a move that would further decrease Hong Kong's democratic functioning, China has introduced a law to allow the communist government veto powers over selecting Hong Kong's lawmakers. The move has invited international criticism and the EU has asked Beijing to carefully consider the political and economic implications of any decision to reform the electoral system of Hong Kong that would undermine fundamental freedoms, political pluralism, and democratic principles. A temporary US ban on exports of critical raw materials through the recent invocation of the US Defence Production Act to preserve vaccine raw materials for its own companies could limit vaccine manufacturing by other companies, according to Serum Institute of India's chief executive Adar Poonawalla. As Mr. Poonawalla state there remain lots of "bags, filters and critical items" that manufacturers need from the US, restricting which could severely impact equitable distribution of vaccines. About egomonk: Website | Facebook | Twitter | LinkedInegomonk is a global intelligence platform delivering asymmetric outcomes by bringing organizations closer to the communities they want to serve and the leaders they wish to influence. If you wish to collaborate with us then email us at contact@egomonk.com.

The Serum Institute of India is producing the coronavirus vaccine developed by AstraZeneca Plc- Oxford is expecting the government to sign a formal supply and pricing agreement after the approval for emergency usage of the vaccine. Tune in as Rohini & Sachin discuss the takeaways from the conversation with Adar Poonawalla, CEO, Serum Institute of India

In today's episode, Rahul Gandhi has said that he is not going to lie about Chinese transgressions in eastern Ladakh even if it costs him politically, Adar Poonawalla says that "More than enough" doses of the COVID-19 vaccine developed by Oxford University and AstraZeneca will be reserved for the Parsi community and Rajasthan Governor Kalraj Mishra has agreed to summon a session of the state Assembly provided the government gives a 21-day notice. Download the Deccan Herald app for Android devices here: https://bit.ly/2UgttIO Download the Deccan Herald app for iOS devices here: https://apple.co/30eOFD6 For latest news and updates, log on to www.deccanherald.com Check out our e-paper www.deccanheraldepaper.com To read news on the go, sign up to our Telegram channel t.me/deccanheraldnews

"End of the year we do hope to have millions of doses of the COVID-19 Vaccines, subject to success of the human trials. We will begin the Human trial for the COVID-19 Vaccines, we have started manufacturing, in collaboration with Oxford University- based recent agreement with AstraZeneca " says Adar Poonawalla, CEO Serum Institute Of India on IndiaPodcasts, with Anku Goyal